Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Hindrik Mulder

Hindrik Mulder

Principal investigator

Hindrik Mulder

Orexin loss in Huntington's disease.

Author

  • Åsa Petersén
  • Joana Gil
  • Marion L C Maat-Schieman
  • Maria Björkqvist
  • Heikki Tanila
  • Ines M Araújo
  • Ruben Smith
  • Natalija Popovic
  • Nils Wierup
  • Per Norlén
  • Jia-Yi Li
  • Raymund Ac Roos
  • Frank Sundler
  • Hindrik Mulder
  • Patrik Brundin

Summary, in English

Huntington's disease (HD) is a devastating neurodegenerative disorder caused by an expanded CAG repeat in the gene encoding huntingtin, a protein of unknown function. Mutant huntingtin forms intracellular aggregates and is associated with neuronal death in select brain regions. The most studied mouse model (R6/2) of HD replicates many features of the disease, but has been reported to exhibit only very little neuronal death. We describe for the first time a dramatic atrophy and loss of orexin neurons in the lateral hypothalamus of R6/2 mice. Importantly, we also found a significant atrophy and loss of orexin neurons in Huntington patients. Like animal models and patients with impaired orexin function, the R6/2 mice were narcoleptic. Both the number of orexin neurons in the lateral hypothalamus and the levels of orexin in the cerebrospinal fluid were reduced by 72% in end-stage R6/2 mice compared with wild-type littermates, suggesting that orexin could be used as a biomarker reflecting neurodegeneration. Our results show that the loss of orexin is a novel and potentially very important pathology in HD.

Department/s

  • Translational Neuroendocrinology
  • Department of Experimental Medical Science
  • Basal Ganglia Pathophysiology
  • Division of Clinical Chemistry and Pharmacology
  • Neural Plasticity and Repair
  • Diabetes - Molecular Metabolism

Publishing year

2005

Language

English

Pages

39-47

Publication/Series

Human Molecular Genetics

Volume

14

Issue

1

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Medical Genetics

Status

Published

Research group

  • Translational Neuroendocrinology
  • Basal Ganglia Pathophysiology
  • Neural Plasticity and Repair
  • Diabetes - Molecular Metabolism

ISBN/ISSN/Other

  • ISSN: 0964-6906